Table 2 Comparison of biopsy specimens, safety, diagnosis, and prognosis between the patients underwent TBLB and TBLC
TBLB (n = 45) | TBLC (n = 25) | p value | |
|---|---|---|---|
Specimen (Median, IQR) | |||
Number | 4 (2–6) | 4 (3–5) | 0.380 |
Length diameter, mm | 1.0 (0.5–2.0) | 5.3 (4.8–5.6) | < 0.001 |
Short diameter, mm | 0.5 (0.5–0.8) | 3.7 (3.3–4.3) | < 0.001 |
Artifacts (n, %) | |||
Crash/atelectasis | 25 (55.6) | 0 | < 0.001 |
Traumatic bleeding | 4 (8.9) | 4 (16.0) | 0.443 |
Non-alveolar tissue | 8 (17.8) | 0 | 0.044 |
Complications (n, %) | 7 (15.6) | 7 (28.0) | 0.212 |
Moderate bleeding | 0 | 7 (28.0) | < 0.001 |
Severe bleeding | 0 | 0 | – |
Pneumothorax | 6 (13.3) | 0 | 0.056 |
Others | 1 (2.2) | 0 | 1.000 |
ΔAPACHE II score ≥ 5 (n, %) | 0 | 4 (16.0) | 0.006 |
ΔSOFA score ≥ 3 (n, %) | 1 (2.2) | 4 (16.0) | 0.032 |
Pathological diagnosis (n, %) | 17 (37.8) | 18 (72.0) | 0.006 |
MDD diagnosis (n, %) | 25 (55.6) | 21 (84.0) | 0.016 |
Treatment modifications (n, %) | 26 (57.8) | 21 (84.0) | 0.025 |
28-day survival (n, %) | 25 (55.6) | 16 (64.0) | 0.492 |